Home > National Drug Code (NDC) > Losartan Potassium and Hydrochlorothiazide

Losartan Potassium and Hydrochlorothiazide - 66116-450-30 - (Losartan Potassium and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Losartan Potassium and Hydrochlorothiazide

Product NDC: 66116-450
Proprietary Name: Losartan Potassium and Hydrochlorothiazide
Non Proprietary Name: Losartan Potassium and Hydrochlorothiazide
Active Ingredient(s): 12.5; 50    mg/1; mg/1 & nbsp;   Losartan Potassium and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Losartan Potassium and Hydrochlorothiazide

Product NDC: 66116-450
Labeler Name: MedVantx, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077157
Marketing Category: ANDA
Start Marketing Date: 20101220

Package Information of Losartan Potassium and Hydrochlorothiazide

Package NDC: 66116-450-30
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (66116-450-30)

NDC Information of Losartan Potassium and Hydrochlorothiazide

NDC Code 66116-450-30
Proprietary Name Losartan Potassium and Hydrochlorothiazide
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (66116-450-30)
Product NDC 66116-450
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Losartan Potassium and Hydrochlorothiazide
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20101220
Marketing Category Name ANDA
Labeler Name MedVantx, Inc.
Substance Name HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Strength Number 12.5; 50
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Losartan Potassium and Hydrochlorothiazide


General Information